NEOLEUKIN THERAPEUTICS INC - COM (NLTX)

CUSIP: 64049K104

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / COM
Total 13F shares
17,283,838
Share change
+2,233,024
Total reported value
$14,343,165
Price per share
$0.83
Number of holders
34
Value change
+$1,877,909
Number of buys
12
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 64049K104?
CUSIP 64049K104 identifies NLTX - NEOLEUKIN THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NEOLEUKIN THERAPEUTICS INC - COM (NLTX) as of Q2 2023

As of 30 Jun 2023, NEOLEUKIN THERAPEUTICS INC - COM (NLTX) was held by 34 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 17,283,838 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, Lynx1 Capital Management LP, Redmile Group, LLC, BANK OF AMERICA CORP /DE/, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Western Standard LLC, MORGAN STANLEY, MILLENNIUM MANAGEMENT LLC, and BlackRock Inc.. This page lists 34 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.